Ashland Inc. (NYSE: ASH) reported fiscal second‑quarter 2026 results on April 28, 2026, with revenue of $482 million, a 1 % year‑over‑year increase, and adjusted earnings per share of $0.91. The company missed consensus estimates of $0.95 to $0.97 per share and revenue expectations of roughly $491 million.
Adjusted operating income fell to $54 million from $60 million a year earlier, and adjusted EBITDA declined to $98 million, a 9 % drop from the prior‑year quarter. Management attributed the decline to temporary operational impacts at the Hopewell facility, weather‑related disruptions, and a delay in the startup of the Calvert City plant.
Segment performance showed mixed results. Personal Care sales grew 3 % to $150 million, while Life Sciences sales remained flat at $172 million. Intermediates revenue fell, and specialty additives saw modest growth, reflecting the uneven demand across the company’s portfolio.
Ashland cut its full‑year 2026 revenue outlook to $1.835 billion to $1.870 billion and adjusted EBITDA guidance to $385 million to $400 million, down from the previous range of $1.90 billion to $1.95 billion and $400 million to $420 million. The guidance reduction signals management’s concern over ongoing operational challenges and a slower than expected productivity ramp at the new manufacturing site.
CEO Guillermo Novo said, 'The second‑quarter results reflect commercial execution across much of the portfolio as we navigated a challenging operating environment with generally resilient demand.' He added that the company remains focused on cash generation, balance‑sheet strength, and disciplined capital allocation to improve resilience.
Investors reacted negatively to the earnings miss and lowered guidance, citing the operational headwinds at Hopewell and the Calvert City startup delay as key concerns.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.